|
Market Cap (10-Jun) $44,934,040 (0th) |
Close (30-Jun) $0.105 |
Volume (30-Jun) 1,951,148 |
Shortsold (26-May) 2,077,074 (0.06%) (491st) |
|
52w High $0.040 |
52w Low $0.017 |
P/E - |
EPS -0.02 |
A news article has been posted about Radiopharm Theranostics on the AFR. The article was published around , on 17 March 2022 at 5:33am.
Overseas CEOs from Chimeric Therapeutics, BCAL Diagnostics and Radiopharm Theranostics are fronting local investors, hoping to shore up support amid the sell-off.
Read ArticleRAD was $0.27 at the close of trade on 16 March 2022
Find all articles about Radiopharm Theranostics, including others on the AFR, on the media page.
You must be logged in to post a reply.
